JMP Securities Thinks Sabra Healthcare REIT’s Stock is Going to Recover

In a report released today, Aaron Hecht from JMP Securities reiterated a Buy rating on Sabra Healthcare REIT (SBRAResearch Report), with a price target of $16.00. The company’s shares closed last Monday at $12.80, close to its 52-week low of $12.31.

According to, Hecht is a 4-star analyst with an average return of 11.1% and a 58.7% success rate. Hecht covers the Financial sector, focusing on stocks such as Chicago Atlantic Real Estate ate Finance Inc, Bluerock Residential Growth, and Plymouth Industrial Reit.

Sabra Healthcare REIT has an analyst consensus of Strong Buy, with a price target consensus of $17.00, a 30.4% upside from current levels. In a report issued on February 3, BMO Capital also maintained a Buy rating on the stock with a $18.00 price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $19.02 and a one-year low of $12.31. Currently, Sabra Healthcare REIT has an average volume of 2.2M.

Based on the recent corporate insider activity of 77 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SBRA in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing, and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Read More on SBRA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More